A Critical Role of CD30 Ligand/CD30 in Controlling Inflammatory Bowel Diseases in Mice

Gastroenterology

Volumn 134, Issue 2, 2008, Pages

  Sun, Xun ^a   Somada, Shinichi ^a   Shibata, Kensuke ^a   Muta, Hiromi ^a   Yamada, Hisakata ^a   Yoshihara, Hirofumi ^a   Honda, Kuniomi ^a   Nakamura, Kazuhiko ^a   Takayanagi, Ryhoichi ^a   Tani, Kenzaburo ^a   Podack, Eckhard R ^b   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 LIGAND; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 30; OXAZOLONE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; IN VIVO STUDY; LAMINA PROPRIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 38649135387     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.004     Document Type: Article

References (44)

1. Macdonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
3. Sartor R.B. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 148 (1997) 567-576
4. Maaser C., and Kagnoff M.F. Role of the intestinal epithelium in orchestrating innate and adaptive mucosal immunity. Gastroenterology 40 (2002) 525-529
5. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
6. Targan S.R., and Karp L.C. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 206 (2005) 296-305
7. Cobrin G.M., and Abreu M.T. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev 206 (2005) 277-295
8. Kuhn R., Lohler J., Rennick D., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
9. + T cells. Immunity 1 (1994) 553-562
10. Morris G.P., Beck P.L., Herridge M.S., et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989) 795-803
11. Neurath M.F., Fuss I., Kelsall B.L., et al. antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182 (1995) 1281-1290
12. Fuss I.J., Marth T., Neurath M.F., et al. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 117 (1999) 1078-1088
13. Fichtner-Feigl S., Fuss L.J., Preiss J.C., et al. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides. J Clin Invest 115 (2005) 3057-3071
14. Sadlack B., Merz H., Schorle H., et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
15. Mombaerts P., Mizoguchi E., Grusby M.J., et al. Spontaneous development of inflammatory bowel disease in T-cell receptor mutant mice. Cell 75 (1993) 275-282
16. Boirivant M., Fuss I.J., Chu A., et al. Oxazalone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 188 (1998) 129-139
17. Heller F., Fuss I.J., Nieuwenhuis E.E., et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17 (2002) 629-638
18. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat Rev Immunol 3 (2003) 609-620
19. Kennedy M.K., Willis C.R., and Armitage R.J. Deciphering CD30 ligand biology and its role in humoral immunity. Immunology 118 (2006) 143-152
20. Shimozato O., Takeda K., Yagita H., et al. Expression of CD30 ligand (CD153) on murine activated T cells. Biochem Biophys Res Commun 256 (1999) 519-526
21. + B cells. J Immunol 165 (2000) 786-794
22. - accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 8 (2003) 643-653
23. + T cells. J Immunol 151 (1993) 2380-2389
24. Bowen M.A., Lee R.K., Miragliotta G., et al. Structure and expression of murine CD30 and its role in cytokine production. J Immunol 156 (1996) 442-449
25. Smith C.A., Gruss H.J., Davis T., et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 (1993) 1349-1360
26. Romagnani S., Del Prete G., Maggi E., et al. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 57 (1995) 726-530
27. + cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int Immunol 9 (1997) 713-720
28. -1BBL to the optimal induction of protective immunity to Mycobacterium avium. J Leukoc Biol 76 (2004) 1039-1046
29. + T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol 22 (2001) 72-77
30. Saraiva M., Smith P., Fallon P.G., et al. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med 196 (2002) 829-839
31. Giacomelli R., Passacantando A., Parzanese I., et al. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's-disease (CD). Clin Exp Immunol 111 (1998) 532-535
32. Podack E.R., Strbo N., Sotosec V., et al. CD30-Governor of memory T cells?. Ann N Y Acad Sci 975 (2002) 101-113
33. +T cells. J Immunol 175 (2005) 4627-4634
34. Yoshihara K., Yajima T., Kubo C., et al. The role of IL-15 in colitis induced by dextran sulphate sodium in mice. Gut 55 (2006) 334-341
35. + regulatory T cells. J Immunol 172 (2004) 5986-5993
36. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nat Rev Immunol 2 (2002) 933-944
37. Ansel K.M., Djuretic I., Tanasa B., et al. Regulation of Th2 differentiation and IL-4 locus accessibility. Annu Rev Immunol 24 (2006) 607-656
38. Fuss I.J., Heller F., Boirivant M., et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113 (2004) 1490-1497
39. Iijima H., Neurath M.F., Nagaishi T., et al. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med 199 (2004) 471-482
40. + T cell-mediated graft-versus-host disease. J Immunol 173 (2004) 2933-2941
41. Muta H., Boise L.H., Fang L., et al. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol 165 (2000) 5105-5111
42. Asseman C., Mauze S., Leach M.W., et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190 (1999) 995-1004
43. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
44. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 (2003) 388-392